Drug Delivery Methods Based on Nanotechnology for the Treatment of Eye Diseases

Overview

Journal Ann Med Surg (Lond)

Publisher Wolters Kluwer

Specialty Medical Education

Date 2023 Dec 15

PMID 38098602

Authors

Mohammed Tayeb Oucif Khaled

Abdelmalekd Zaater

Ilham Ben Amor

Soumeia Zeghoud

Asma Ben Amor

Hadia Hemmami

Ali Alnazza Alhamad

Affiliations

Soon will be listed here.

Abstract

One of the most difficult tasks among the numerous medication delivery methods is ocular drug delivery. Despite having effective medications for treating ocular illness, we have not yet managed to develop an appropriate drug delivery strategy with the fewest side effects. Nanotechnology has the potential to significantly address the drawbacks of current ocular delivery systems, such as their insufficient therapeutic effectiveness and unfavourable side effects from invasive surgery or systemic exposure. The objective of the current research is to highlight and update the most recent developments in nano-based technologies for the detection and treatment of ocular diseases. Even if more work has to be done, the advancements shown here might lead to brand-new, very practical ocular nanomedicines.

Citing Articles

Harnessing Corneal Stromal Regeneration for Vision Restoration: A Comprehensive Review of the Emerging Treatment Techniques for Keratoconus.

Javed Z, Daigavane S Cureus. 2024; 16(9):e69835.

PMID: 39435192 PMC: 11492026. DOI: 10.7759/cureus.69835.

Recent developments in cancer diagnosis and treatment using nanotechnology.

Ouled Ltaief O, Ben Amor I, Hemmami H, Hamza W, Zeghoud S, Ben Amor A Ann Med Surg (Lond). 2024; 86(8):4541-4554.

PMID: 39118776 PMC: 11305775. DOI: 10.1097/MS9.0000000000002271.

References

Tonglairoum P, Brannigan R, Opanasopit P, Khutoryanskiy V . Maleimide-bearing nanogels as novel mucoadhesive materials for drug delivery. J Mater Chem B. 2020; 4(40):6581-6587. DOI: 10.1039/c6tb02124g. View

Ahmadkhani L, Mostafavi E, Ghasemali S, Baghban R, Pazoki-Toroudi H, Davaran S . Development and characterization of a novel conductive polyaniline-g-polystyrene/FeO nanocomposite for the treatment of cancer. Artif Cells Nanomed Biotechnol. 2019; 47(1):873-881. DOI: 10.1080/21691401.2019.1575839. View

Tagalakis A, Madaan S, Larsen S, Neubig R, Khaw P, Rodrigues I . In vitro and in vivo delivery of a sustained release nanocarrier-based formulation of an MRTF/SRF inhibitor in conjunctival fibrosis. J Nanobiotechnology. 2018; 16(1):97. PMC: 6258153. DOI: 10.1186/s12951-018-0425-3. View

Heurtault B, Saulnier P, Pech B, Proust J, Benoit J . Physico-chemical stability of colloidal lipid particles. Biomaterials. 2003; 24(23):4283-300. DOI: 10.1016/s0142-9612(03)00331-4. View

Tan G, Yu S, Pan H, Li J, Liu D, Yuan K . Bioadhesive chitosan-loaded liposomes: A more efficient and higher permeable ocular delivery platform for timolol maleate. Int J Biol Macromol. 2016; 94(Pt A):355-363. DOI: 10.1016/j.ijbiomac.2016.10.035. View

Khalil I, Ali I, El-Sherbiny I . Noninvasive biodegradable nanoparticles-in-nanofibers single-dose ocular insert: in vitro, ex vivo and in vivo evaluation. Nanomedicine (Lond). 2018; 14(1):33-55. DOI: 10.2217/nnm-2018-0297. View

Zolnik B, Gonzalez-Fernandez A, Sadrieh N, Dobrovolskaia M . Nanoparticles and the immune system. Endocrinology. 2009; 151(2):458-65. PMC: 2817614. DOI: 10.1210/en.2009-1082. View

Kumar R, Sinha V . Solid lipid nanoparticle: an efficient carrier for improved ocular permeation of voriconazole. Drug Dev Ind Pharm. 2016; 42(12):1956-1967. DOI: 10.1080/03639045.2016.1185437. View

Fu T, Yi J, Lv S, Zhang B . Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy. J Liposome Res. 2016; 27(3):228-233. DOI: 10.1080/08982104.2016.1224899. View

10.

Zamboulis A, Nanaki S, Michailidou G, Koumentakou I, Lazaridou M, Ainali N . Chitosan and its Derivatives for Ocular Delivery Formulations: Recent Advances and Developments. Polymers (Basel). 2020; 12(7). PMC: 7407599. DOI: 10.3390/polym12071519. View

11.

Barani M, Nematollahi M, Zaboli M, Mirzaei M, Torkzadeh-Mahani M, Pardakhty A . In silico and in vitro study of magnetic niosomes for gene delivery: The effect of ergosterol and cholesterol. Mater Sci Eng C Mater Biol Appl. 2018; 94:234-246. DOI: 10.1016/j.msec.2018.09.026. View

12.

Weng Y, Ma X, Che J, Li C, Liu J, Chen S . Nanomicelle-Assisted Targeted Ocular Delivery with Enhanced Antiinflammatory Efficacy In Vivo. Adv Sci (Weinh). 2018; 5(1):1700455. PMC: 5770669. DOI: 10.1002/advs.201700455. View

13.

Hajizadeh M, Maleki H, Barani M, Fahmidehkar M, Mahmoodi M, Torkzadeh-Mahani M . cytotoxicity assay of D-limonene niosomes: an efficient nano-carrier for enhancing solubility of plant-extracted agents. Res Pharm Sci. 2019; 14(5):448-458. PMC: 6827193. DOI: 10.4103/1735-5362.268206. View

14.

Ways T, Lau W, Khutoryanskiy V . Chitosan and Its Derivatives for Application in Mucoadhesive Drug Delivery Systems. Polymers (Basel). 2019; 10(3). PMC: 6414903. DOI: 10.3390/polym10030267. View

15.

Liu D, Lian Y, Fang Q, Liu L, Zhang J, Li J . Hyaluronic-acid-modified lipid-polymer hybrid nanoparticles as an efficient ocular delivery platform for moxifloxacin hydrochloride. Int J Biol Macromol. 2018; 116:1026-1036. DOI: 10.1016/j.ijbiomac.2018.05.113. View

16.

Coursey T, Henriksson J, Marcano D, Shin C, Isenhart L, Ahmed F . Dexamethasone nanowafer as an effective therapy for dry eye disease. J Control Release. 2015; 213:168-174. DOI: 10.1016/j.jconrel.2015.07.007. View

17.

Chu K, Schorzman A, Finniss M, Bowerman C, Peng L, Luft J . Nanoparticle drug loading as a design parameter to improve docetaxel pharmacokinetics and efficacy. Biomaterials. 2013; 34(33):8424-9. PMC: 3807740. DOI: 10.1016/j.biomaterials.2013.07.038. View

18.

Weng Y, Liu J, Jin S, Guo W, Liang X, Hu Z . Nanotechnology-based strategies for treatment of ocular disease. Acta Pharm Sin B. 2017; 7(3):281-291. PMC: 5430571. DOI: 10.1016/j.apsb.2016.09.001. View

19.

Vo A, Feng X, Patel D, Mohammad A, Kozak D, Choi S . Factors affecting the particle size distribution and rheology of brinzolamide ophthalmic suspensions. Int J Pharm. 2020; 586:119495. DOI: 10.1016/j.ijpharm.2020.119495. View

20.

Yu F, Zheng M, Zhang A, Han Z . A cerium oxide loaded glycol chitosan nano-system for the treatment of dry eye disease. J Control Release. 2019; 315:40-54. PMC: 6925533. DOI: 10.1016/j.jconrel.2019.10.039. View